AI
IDXX icon

Axiom Investors’s Idexx Laboratories IDXX Stock Holding History

Axiom Investors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-59,677
Closed -$32.2M – 136
2024
Q1 		$32.2M Buy
59,677
+798
+1% +$436K 0.28% 47
2023
Q4 		$32.7M Sell
58,879
-71,054
-55% -$33.4M 0.32% 48
2023
Q3 		$56.8M Sell
129,933
-129,418
-50% -$64.5M 0.82% 34
2023
Q2 		$130M Buy
259,351
+4,750
+2% +$2.28M 1.94% 17
2023
Q1 		$127M Buy
254,601
+86,795
+52% +$41.5M 2.1% 17
2022
Q4 		$68.5M Buy
167,806
+37,890
+29% +$14.7M 1.35% 24
2022
Q3 		$42.3M Buy
129,916
+28,152
+28% +$10.3M 0.89% 34
2022
Q2 		$35.7M Buy
101,764
+447
+0.4% +$182K 1.07% 28
2022
Q1 		$55.4M Sell
101,317
-56,070
-36% -$29.5M 1.31% 25
2021
Q4 		$104M Buy
157,387
+7,322
+5% +$4.6M 1.91% 16
2021
Q3 		$93.3M Sell
150,065
-62,294
-29% -$41.9M 1.54% 23
2021
Q2 		$134M Buy
212,359
+41,927
+25% +$23.2M 2.16% 12
2021
Q1 		$83.4M Buy
170,432
+4,026
+2% +$2.02M 1.51% 19
2020
Q4 		$83.2M Sell
166,406
-480
-0.3% -$215K 1.31% 25
2020
Q3 		$65.6M Buy
166,886
+49,683
+42% +$18.4M 1.06% 25
2020
Q2 		$38.7M Buy
117,203
+9,849
+9% +$2.85M 0.76% 35
2020
Q1 		$26M Buy
107,354
+7,923
+8% +$2.07M 0.66% 37
2019
Q4 		$26M Buy
99,431
+4,880
+5% +$1.29M 0.6% 48
2019
Q3 		$25.7M Sell
94,551
-37,715
-29% -$10.5M 0.69% 44
2019
Q2 		$36.4M Buy
132,266
+40,823
+45% +$10.1M 1% 30
2019
Q1 		$20.4M Buy
+91,443
New +$18.9M 0.63% 39

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Axiom Investors's IDXX Position: Q2 2024 in Review

Axiom Investors sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 59,677 shares — an estimated $32.2M sold.

Axiom Investors first reported a position in IDXX in Q1 2019 and held it in 21 quarters. The position peaked at $134M in Q2 2021. 1,109 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Axiom Investors reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Axiom Investors sold 59,677 Idexx Laboratories shares in Q2 2024, an estimated $32.2M.
  • Axiom Investors first reported a position in Idexx Laboratories in Q1 2019 and held it in 21 quarters.
  • Axiom Investors's Idexx Laboratories position peaked at $134M in Q2 2021.
  • 1,109 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Axiom Investors's 13F filing for Q2 2024, filed 13 Aug 2024.